The BYLIMIR brand, founded in 2013 (Japan), from 440 sister brands and 4958 competing brands. BYLIMIR is owned by Takeda Pharmaceutical, listed on the stock exchange of Francfort Its International Securities Identification Number (ISIN) is JP3463000004. BYLIMIR belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Takeda Pharmaceutical
(BYLIMIR)
over 5 years*
EUR 18.51